ATI RN
Cardiovascular System Exam
1. When administering enoxaparin (Lovenox) to a client, what is the most important lab value to monitor?
- A. Platelet count
- B. aPTT
- C. Hemoglobin
- D. INR
Correct answer: A
Rationale: The correct answer is A: Platelet count. When administering enoxaparin (Lovenox), it is crucial to monitor the platelet count because enoxaparin can cause a rare but serious side effect known as heparin-induced thrombocytopenia, which is a decrease in platelet count that can lead to increased risk of bleeding. Monitoring the platelet count allows for early detection of this potential complication. Choices B, C, and D are incorrect because aPTT, Hemoglobin, and INR are not the most important lab values to monitor specifically when administering enoxaparin.
2. A client on a beta blocker has a heart rate of 52 bpm. What is the nurse’s priority action?
- A. Hold the beta blocker and notify the healthcare provider.
- B. Administer the beta blocker as ordered.
- C. Increase the dose of the beta blocker.
- D. Continue to monitor the client and reassess in 30 minutes.
Correct answer: A
Rationale: The correct answer is to hold the beta blocker and notify the healthcare provider. A heart rate of 52 bpm is low, and beta blockers can further decrease the heart rate, potentially causing harm. Therefore, withholding the medication and promptly informing the healthcare provider is crucial for further assessment and possible adjustment of the treatment plan. Administering the beta blocker as ordered (Choice B) can exacerbate the bradycardia. Increasing the dose of the beta blocker (Choice C) would further suppress the heart rate. Continuing to monitor the client and reassessing in 30 minutes (Choice D) might delay necessary interventions and increase the risk of complications in a client with a heart rate of 52 bpm.
3. What is a chronic condition where the airways in the lungs become damaged and widened, leading to mucus buildup and frequent infections?
- A. Bronchiectasis
- B. Chronic bronchitis
- C. Pneumoconiosis
- D. Asthma
Correct answer: A
Rationale: Bronchiectasis is a chronic condition characterized by the damage and widening of the airways in the lungs, resulting in mucus accumulation and recurrent lung infections. Choice B, chronic bronchitis, involves inflammation of the bronchial tubes and excessive mucus production but does not specifically mention airway damage and widening. Choice C, pneumoconiosis, refers to lung diseases caused by inhalation of mineral dust particles, not airway damage and mucus buildup. Choice D, asthma, is a chronic condition characterized by airway inflammation and narrowing, leading to breathing difficulties, but it does not involve the widening and damage of the airways as seen in bronchiectasis.
4. The client is on hydrochlorothiazide and digoxin. What effect can the nurse expect?
- A. Hydrochlorothiazide increases digoxin levels.
- B. Hydrochlorothiazide decreases digoxin levels.
- C. Hydrochlorothiazide decreases potassium, increasing the risk of digoxin toxicity.
- D. Digoxin can increase the effectiveness of hydrochlorothiazide.
Correct answer: C
Rationale: The correct answer is C. Hydrochlorothiazide is a diuretic that can decrease potassium levels, which in turn can increase the risk of digoxin toxicity. Digoxin typically doesn't impact hydrochlorothiazide levels or effectiveness, making choices A, B, and D incorrect. Choice A stating that hydrochlorothiazide increases digoxin levels is inaccurate. Choice B suggesting that hydrochlorothiazide decreases digoxin levels is also incorrect. Choice D, stating that digoxin can increase the effectiveness of hydrochlorothiazide, is not a typical interaction seen between these medications.
5. When administering an ACE inhibitor to a client with heart failure, what is the expected outcome of this medication?
- A. Decreased blood pressure
- B. Increased heart rate
- C. Increased cardiac output
- D. Decreased heart rate
Correct answer: C
Rationale: The correct answer is C: Increased cardiac output. ACE inhibitors are commonly used in heart failure to reduce the workload on the heart by decreasing blood pressure and increasing cardiac output. This ultimately helps improve the heart's efficiency and function. Choice A is incorrect because ACE inhibitors generally lead to a reduction in blood pressure. Choice B is incorrect as ACE inhibitors do not increase heart rate. Choice D is incorrect as ACE inhibitors do not typically decrease heart rate in the context of heart failure.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access